AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
A study presented in the AACR Annual Meeting 2018 Media Preview webinar, held March 15, examined closely a key...
In less than a month, the AACR Annual Meeting 2018 will kick off in Chicago, Illinois. The meeting is...
A recent blog post by the Sidney Kimmel Cancer Center – Jefferson Health examined whether the power of immunotherapy...
Editor’s note: February is Cancer Prevention Month. That’s why the American Association for Cancer Research (AACR) has been pleased...
Cigarette smoking is linked to 18 different types of cancer. It is the leading preventable cause of cancer in...
Together with the Radiation Research Society, the AACR will present a workshop titled Targeting Cancer Metabolism to Improve Radiotherapy...
The U.S. Food and Drug Administration (FDA) recently approved expanding the use of the immunotherapeutic durvalumab (Imfinzi) to include...
Last week, the U.S. Food and Drug Administration (FDA) approved the antihormone agent apalutamide (Erleada) for treating men with...
The field of medical oncology is undergoing a remarkable transformation. Cancers that were once considered death sentences, such as...
Before her husband, Tony, was diagnosed with stomach cancer in 2012, Christy Leonard knew little about caregiving. Leonard, who...